|
"tseng p l"的相關文件
顯示項目 1-10 / 10 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2022-04-21T06:51:12Z |
Community-based mass ultrasonographic screening of hepatocellular carcinoma among thrombocytopenic adults
|
Lu S.-N.; Wang J.-H.; Chen P.-F.; Tung H.-D.; Tseng P.-L.; Hung C.-H.; Kee K.-M.; Chen C.-H.; Chang K.-C.; Lee C.-M.; Changchien C.-S.; Chen Y.-D.; Tsai L.-S.; Chen, Tony Hsiu Hsi |
| 臺大學術典藏 |
2022-04-21T06:50:48Z |
Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy
|
Chang K.-C.; Wu Y.-Y.; Hung C.-H.; Lu S.-N.; Lee C.-M.; Chiu K.-W.; Tsai M.-C.; Tseng P.-L.; Huang C.-M.; Cho C.-L.; Chen, Tony Hsiu Hsi; Hu T.-H. |
| 臺大學術典藏 |
2022-04-21T06:50:39Z |
A polymorphism in interferon L3 Is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis c virus infection
|
Chang K.-C.; Tseng P.-L.; Wu Y.-Y.; Hung H.-C.; Huang C.-M.; Lu S.-N.; Wang J.-H.; Lee C.-M.; Chen C.-H.; Tsai M.-C.; Yen Y.-H.; Lin M.-T.; Wu C.-K.; Huang C.-C.; Chen, Tony Hsiu Hsi; Hu T.-H. |
| 臺大學術典藏 |
2018-09-10T15:17:28Z |
A polymorphism in interferon L3 Is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis c virus infection
|
Chang, K.-C. ; Tseng, P.-L. ; Wu, Y.-Y. ; Hung, H.-C. ; Huang, C.-M. ; Lu, S.-N. ; Wang, J.-H. ; Lee, C.-M. ; Chen, C.-H. ; Tsai, M.-C. ; Yen, Y.-H. ; Lin, M.-T. ; Wu, C.-K. ; Huang, C.-C. ; Chen, H.-H. ; Hu, T.-H.; HSIU-HSI CHEN |
| 臺大學術典藏 |
2018-09-10T09:41:04Z |
Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy
|
Chang, K-C;Wu, Y-Y;Hung, C-H;Lu, S-N;Lee, C-M;Chiu, K-W;Tsai, M-C;Tseng, P-L;Huang, C-M;Cho, C-L;Chen, H-H;Hu, T-H; HSIU-HSI CHEN; Chang, K-C; Wu, Y-Y; Hung, C-H; Lu, S-N; Lee, C-M; Chiu, K-W; Tsai, M-C; Tseng, P-L; Huang, C-M; Cho, C-L; Chen, H-H; Hu, T-H |
| 臺大學術典藏 |
2018-09-10T09:22:02Z |
Roll-to-roll device fabrication on flexible glass web
|
Merz, G.; Tosch, J.; Chang, C.; Lin, J.C.; Kuo, K.T.; Tseng, P.L.; Chang, H.F.; Lewis, S.; Kohler, R.; Tian, L.; Simpson, L.; Owens, M.; Li, X.; Huang, S.; Shih, J.; Wei, A.; Lin, M.C.; Huang, C.S.; Lin, H.T.; Lin, C.L.; Chang, S.Y.; Wang, C.T.; Shen, J.; Hsiao, C.H.; Lu, S.T.; Hu, J.; Liu, C.T.; Switzer, J.; Steiner, J.; Garner, S.; CHING-FUH LINet al. |
| 國立成功大學 |
2018 |
The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but sensitizes cancer cells to 2-deoxyglucose inhibition
|
Tseng, P.-L.;Chen, Chen C.-W.;Hu, K.-H.;Cheng, H.-C.;Lin, Y.H.;Tsai, W.-H.;Cheng, T.-J.;Wu, Wu W.-H.;Yeh, C.-W.;Lin, C.C.;Tsai, H.-J.;Chang, H.-C.;Chuang, J.-H.;Shan, Y.-S.;Chang, W.-T. |
| 國立臺灣科技大學 |
2013 |
Study and implementation of a two-phase interleaved bridgeless buck power factor corrector
|
Liu, Y.-C.;Pan, T.-F.;Tseng, P.-L.;Huang, C.-C.;La, Y.-K.;Chiu, H.-J. |
| 國立臺灣大學 |
2013 |
Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy
|
Chang, K-C; Wu, Y-Y; Hung, C-H; Lu, S-N; Lee, C-M; Chiu, K-W; Tsai, M-C; Tseng, P-L; Huang, C-M; Cho, C-L; Chen, H-H; Hu, T-H; 陳秀熙 |
| 臺大學術典藏 |
2010 |
The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care Patients: A meta-analysis
|
Lin P.-C.; CHIA-HSUIN CHANG; Hsu P.-I.; Tseng P.-L.; Huang Y.-B. |
顯示項目 1-10 / 10 (共1頁)
1
每頁顯示[10|25|50]項目
|
